Executive readout · one minute
Call research workspace
Read the call alongside every captured source. slides, 8-K earnings release, 8-K call announcement, 10-Q stay in one workspace.
ELTX
$2.05
-2.84%
ELTX
· Elicio Therapeutics, Inc.
$2.05
-0.06 (-2.84%)
At close · Sep 11
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We are currently facing substantial doubt about our ability to continue as a going concern, given our cash position and cash runway.”View the 10-Q filed Aug 13, 2026
Market Cap
$53.88M
Shares
26.28M
All earnings calls
Earnings call · FY2026 Q1
Elicio Therapeutics, Inc. (ELTX) Q1 2026 Earnings Call
Research coverage
4 live sources
Open each available source without leaving this research workspace.
Diluted EPS
-$0.65
Net income
-$11.82M
Research materials
Open the source you need; every reader stays inside this workspace.
Company presentation
Slides
16 pages · use arrow keys or swipe to navigate
SEC filing · Item 2.02
8-K earnings release
Filed May 11, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed May 11, 2026 · complete as-filed document
SEC call announcement
8-K call announcement
Filed Jun 15, 2026 · complete as-filed document